DelMar Pharmaceuticals, Inc. Purchase Agreements
9 Contracts & Agreements
- Asset Purchase Agreement, dated January 26, 2023, between TuHURA Biopharma Inc. and Morphogenesis, Inc (Filed With SEC on May 13, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 24, 2023)
- Purchase Agreement, dated as of August 2, 2022, by and between Kintara Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2022)
- Form of Securities Purchase Agreement, dated April 12, 2022, by and between Kintara Therapeutics, Inc. and the purchasers named therein (Filed With SEC on April 13, 2022)
- Form of Securities Purchase Agreement, dated September 23, 2021 (Filed With SEC on September 28, 2021)
- Amendment to Asset Purchase Agreement, dated as of May 12, 2014, by and between Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC (Filed With SEC on June 16, 2020)
- Asset Purchase Agreement, dated as of November 26, 2012, by and between Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC (Filed With SEC on June 16, 2020)
- Form of Purchase Agreement, dated as of June 3, 2019 among DelMar Pharmaceuticals, Inc. and the purchasers thereunder (Filed With SEC on June 3, 2019)
- Form of Purchase Agreement, dated as of September 20, 2017 among DelMar Pharmaceuticals, Inc. and the purchasers thereunder (Filed With SEC on September 21, 2017)
